| 1 |
LU1176839154 |
Protea Fund - Sectoral Biotech Opportunities Fund IF USD |
+16,50 % |
+22,08 % |
0,66 |
| 2 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
+16,34 % |
+22,19 % |
0,65 |
| 3 |
LU2208649280 |
UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse QL-acc, USD |
+16,36 % |
+22,46 % |
0,64 |
| 4 |
LU0400035332 |
UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse Q-acc, USD |
+16,12 % |
+22,46 % |
0,63 |
| 5 |
LU0133360163 |
Candriam Equities L Biotechnology, I - Capitalisation |
+15,58 % |
+22,00 % |
0,62 |
|
|
| 54 |
LU2441283277 |
Janus Henderson Horizon Biotechnology Fund H2 HEUR |
+8,75 % |
+28,48 % |
0,24 |
|
|
| 85 |
LU0415392678 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I EUR - Accumulating |
-8,13 % |
+14,17 % |
-0,72 |
| 86 |
LU0415392249 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating |
-8,77 % |
+14,17 % |
-0,76 |
| 87 |
LU2719280096 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 CHF - Accumulating |
-9,12 % |
+14,54 % |
-0,76 |
| 88 |
LU0415392835 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating |
-9,23 % |
+14,54 % |
-0,77 |
| 89 |
LU0415392595 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating |
-9,86 % |
+14,54 % |
-0,82 |